FDA Inspection 1253952 — Versiti Illinois Inc

Versiti Illinois Inc — FEI 3008393297

The FDA completed an inspection of Versiti Illinois Inc on November 6, 2024 in Bloomingdale, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 6, 2024
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Bloomingdale, IL (United States)